Lataa...
Expert opinion—management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors
Regardless of line of therapy, treatment goals in chronic phase chronic myeloid leukemia (CML) are: avoid progression to accelerated phase or blast crisis CML such that patients achieve a life expectancy comparable with that of the general population; avoid adverse events (AEs); and restore and main...
Tallennettuna:
| Julkaisussa: | Leukemia |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7266739/ https://ncbi.nlm.nih.gov/pubmed/32366938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-020-0842-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|